U.S. Intravenous (IV) Solutions Market size was USD 3.91 Billion in 2025 and is expected to reach USD 8.39 Billion by 2035 owing to advanced healthcare infrastructure globally
Austin, March 13, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, the Intravenous (IV) Solutions Market Size was valued at USD 13.35 Billion in 2025 and is expected to reach USD 29.47 Billion by 2035 and grow at a CAGR of 8.24% over 2026-2035.
IV Remedies The increase in the prevalence of chronic illnesses and critical care conditions, such as cancer, heart disease, malnutrition, and desiccation is what propels market expansion. The need for IV solutions has significantly increased due to the growing number of pediatric and elderly patients seeking hospital admissions and surgical procedures, as well as the rising demand for parenteral feeding solutions.
Intravenous (IV) Solutions Market Size and Forecast:
- Market Size in 2025: USD 13.35 Billion
- Market Size by 2035: USD 29.47 Billion
- CAGR: 8.24% from 2026 to 2035
- Base Year: 2025
- Forecast Period: 2026–2035
- Historical Data: 2022–2024
Get Exclusive Access to the Sample Report of Intravenous (IV) Solutions Market Forecast @ https://www.snsinsider.com/sample-request/8807
The U.S. Intravenous (IV) Solutions Market size was USD 3.91 Billion in 2025 and is expected to reach USD 8.39 Billion by 2035, growing at a CAGR of 7.93% over the forecast period of 2026-2035.
The U.S. market growth is driven by advanced healthcare infrastructure, high adoption of innovative IV therapies, strong hospital networks, and growing demand for nutritional support, fluid management, and critical care across hospitals and home healthcare settings.
Rising Chronic Diseases to Boost Market Expansion Globally
IV (Intravenous) Solutions One of the main factors driving the IV Solutions Market’s growth is the prevalence of chronic illnesses like cancer, heart disease, kidney failure, and malnutrition. Intravenous solutions are the only effective way to provide parenteral nutrition, fluid replacement, and electrolyte balance to patients with these diseases. Demand is further fueled by rising hospital admissions, operations, and critical care needs for the elderly and pediatric populations. IV therapy is becoming a standardized treatment used by healthcare professionals, which is driving the market’s growth.
Intravenous (IV) Solutions Market Segmentation Analysis:
By Type
In 2025, Total parenteral nutrition led the market with a share of 65.10% due to its extensive use in hospitals, clinics, and home care settings for patients requiring complete nutritional support. Peripheral parenteral nutrition is the fastest-growing segment with a CAGR of 8.90% due to the rising awareness of targeted, short-term nutritional therapies, convenience of peripheral administration, and growing adoption in ambulatory and home healthcare facilities.
By Composition
In 2025, Parenteral lipid emulsion led the market with a share of 32.60% due to its essential role in providing high-calorie nutritional support to critically ill and malnourished patients. Single-dose amino acids is the fastest-growing segment with a CAGR of 9.20% fueled by the rising need for precise, patient-specific amino acid supplementation, ease of administration, and growing adoption in home healthcare and specialty medical facilities.
By Application
In 2025, Nutritional support led the market with a share of 55.60% due to the growing prevalence of chronic diseases, malnutrition, post-surgical recovery needs, and critical care requirements. Fluid and electrolyte balance is the fastest-growing segment with a CAGR of 8.70% supported by increasing cases of dehydration, electrolyte imbalances, and critical care interventions globally.
By End-Use
In 2025, Hospitals and clinics led the market with a share of 70.20% due to the high demand for IV solutions in critical care, surgical procedures, and chronic disease management. The home care settings is the fastest-growing segment with a CAGR of 9.50% driven by the increasing preference for at-home treatment, rising awareness of home-based healthcare services, and the convenience of administering IV therapy outside traditional medical facilities.
For a Personalized Briefing with Our Industry Analysts, Connect Now @ https://www.snsinsider.com/request-analyst/8807
Intravenous (IV) Solutions Market Regional Insights:
In 2025, North America is expected to hold over 40.70 % of the revenue share in the Intravenous (IV) Solutions Market as it is characterized by advanced healthcare infrastructure, high rate of chronic and critical illness prevalence, along with intense government funding for healthcare.
The Asia-Pacific region is expected to have the fastest-growing CAGR 9.46%, driven by rising healthcare expenditure, expanding hospital and clinic infrastructure, and increasing awareness of advanced IV therapies.
Major Players Analysis Listed in the Intravenous (IV) Solutions Market Report:
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Grifols, S.A.
- ICU Medical, Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Ajinomoto Co., Inc.
- Terumo Corporation
- Pfizer Inc.
- Hospira, Inc.
- Daiichi Sankyo Company, Limited
- Hikma Pharmaceuticals PLC
- Cardinal Health, Inc.
- Abbott Laboratories
- Novartis AG
- Medline Industries, Inc.
- Chongqing Huapont Pharm Co., Ltd.
- Shanghai Fuxing Pharmaceutical Co., Ltd.
- Taisho Pharmaceutical Co., Ltd.
- CJ Healthcare Corporation
Intravenous (IV) Solutions Market Recent Developments:
- In September 2025, B. Braun received the Nurse Approved Certification for its entire IV Solutions portfolio not made with DEHP or PVC, Plastic Irrigation Containers, and Piperacillin and Tazobactam in DUPLEX® Drug Delivery System, highlighting its commitment to excellence in usability and alignment with nursing practice needs.
- In April 2025, ICU Medical introduced its new category of infusion devices with FDA clearances of Plum Solo and Plum Duo precision IV pumps, offering ±3% accuracy and compatibility with whole blood and blood products.
Purchase Single User PDF of Intravenous (IV) Solutions Market Report @ https://www.snsinsider.com/checkout/8807
Exclusive Sections of the Report (The USPs):
- PATIENT-CENTRIC UTILIZATION METRICS – helps you understand therapy duration trends, patient age demographics, and disease-specific IV solution usage across hospitals, clinics, and home healthcare settings.
- HOSPITAL & HEALTHCARE FACILITY METRICS – helps you evaluate IV pump penetration, hospital bed coverage, and staff training levels that influence IV therapy adoption and operational efficiency.
- PRODUCT INNOVATION & TECHNOLOGY ADOPTION – helps you identify the shift toward pre-mixed IV solutions, advanced nutrient formulations, and automation in IV compounding processes.
- SUPPLY CHAIN & LOGISTICS PERFORMANCE – helps you assess cold chain compliance, delivery lead times, and inventory turnover rates that determine the reliability of IV solution distribution.
- DISEASE-SPECIFIC DEMAND ANALYSIS – helps you identify which therapeutic areas such as oncology, critical care, post-surgery recovery, and malnutrition are driving IV solution consumption.
- HEALTHCARE INFRASTRUCTURE READINESS – helps you gauge how healthcare facility capabilities, infusion technology penetration, and trained medical staff availability impact IV therapy deployment and market growth.
Intravenous (IV) Solutions Market Report Scope:
| Report Attributes | Details |
| Market Size in 2025 | USD 13.35 Million |
| Market Size by 2035 | USD 29.47 Million |
| CAGR | CAGR of 8.24% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Type (Total parenteral nutrition, Peripheral parenteral nutrition) • By Composition (Carbohydrates, Vitamins and minerals, Single-dose amino acids, Parenteral lipid emulsion, Other compositions) • By Application (Nutritional support, Blood transfusion, Fluid and electrolyte balance, Other applications) • By End Use (Hospitals and clinics, Ambulatory surgery centers, Home care settings) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Demand for Industry Analysis: Our Comprehensive Report Intravenous (IV) Solutions Market @ https://www.snsinsider.com/reports/intravenous-solutions-market-8807
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Data Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.
